David Ebsworth - Chairman @ Actimed Therapeutics

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Exits

Unlock for free

Primary Job Title Chairman
Primary Organization
Actimed Therapeutics

Location Zürich, Zurich, Switzerland
Regions Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation
Investor Stage
obfuscated
obfuscation
Number of Exits
obfuscated
obfuscation

LinkedIn View on LinkedIn

David Ebsworth is the Executive Chairman of Actimed Therapeutics. He previously worked at Kyowa Kirin International as a Board Member. David Ebsworth attended the University of Surrey.

Personal Investments

Number of Investments

David Ebsworth

has made

investments. Their latest investment was

Post-IPO Equity - Verona Pharma

obfuscation

, when

Verona Pharma

raised

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Verona Pharma	—	Post-IPO Equity - Verona Pharma	obfuscated obfuscation
obfuscated obfuscation	Small Pharma	No	Seed Round - Small Pharma	obfuscated obfuscation

Exits

Number of Exits

Unlock for free

David Ebsworth

has

obfuscation

exit -

Verona Pharma

David Ebsworth

has

obfuscation

exits. Their most notable exits are

Verona Pharma

and

Small Pharma

Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Small Pharma Small Pharma is dedicated to identifying these opportunities.

Jobs

Number of Current Jobs

David Ebsworth

is the

Chairman

Actimed Therapeutics

Actimed Therapeutics ChairmanNov 2024

Board and Advisor Roles

Number of Current Board & Advisor Roles

David Ebsworth

holds

board and advisor roles including

Chairman Of The Supervisory Board

Synlab

Board Member

Sartorius

, and

Chairman of the Board of Directors

Opterion Health

Synlab Chairman Of The Supervisory BoardJan 2021
Sartorius Board Member2020
Opterion Health Chairman of the Board of Directors2016
Verona Pharma Chairman of the Board2014

Related Hubs

Hub Name	CB Rank (Hub)
Europe, Middle East, and Africa (EMEA) Early Stage Companies With Fewer Than 10 Employees	100,116
Pharmaceutical Early Stage Companies With Less Than $500M in Revenue	50,906
Pharmaceutical Early Stage Companies With Less Than $1B in Revenue	50,973
Pharmaceutical Early Stage Companies With Less Than $10M in Revenue	57,197
Pharmaceutical Companies with Early Stage Venture Funding	43,854
Europe Early Stage Companies With Fewer Than 10 Employees	99,957
Biotechnology Early Stage Companies With Fewer Than 10 Employees	56,163
Pharmaceutical Early Stage Companies With Less Than $50M in Revenue	50,975
Pharmaceutical Early Stage Companies With Fewer Than 50 Employees	53,061
Europe Biotechnology Companies with Early Stage Venture Funding	57,781